Singular Health Receives US$500K as PNS Enterprise Deal Scales
Singular Health receives US$500,000 as PNS enterprise deal scales
Singular Health Group has received US$500,000 from Provider Network Solutions under the existing Binding Enterprise Agreement, following deployment of an additional 500 3DICOM MD licences that fulfil contractual rollout obligations. The payment represents the balance of licence fees under the agreement originally announced 19 June 2025, confirming commercial execution as the platform scales across PNS’s U.S. provider network managing approximately 4.2 million covered lives.
The deployment expands the reach of Singular Health’s 3D medical imaging platform within PNS’s network, which focuses on delivering cost efficiencies and improved patient outcomes across its operations in Florida, Texas and Puerto Rico.
Managing Director and CEO Denning Chong stated: “The receipt of this payment and the deployment of the next tranche of licences represents confirmation by PNS of the value of the 3DICOM MD platform and are important milestones in scaling our commercial reach through PNS and its network and beyond.”
When big ASX news breaks, our subscribers know first
What is 3DICOM MD and why does duplicate imaging matter?
3DICOM MD is Singular Health’s 3D medical imaging platform cleared for diagnostic use in the United States. The platform addresses duplicate imaging, which occurs when healthcare providers order redundant medical scans because they cannot access existing patient imaging records across different healthcare systems.
This redundancy creates unnecessary costs for healthcare plans whilst delaying patient care. The 3DICOM MD platform improves interoperability by enabling image sharing across providers, reducing the frequency of duplicate scans and associated expenses.
For healthcare organisations managing large member populations, the cost impact of duplicate imaging represents a quantifiable problem. The platform’s value proposition centres on eliminating these redundant scans whilst improving workflow efficiency within clinical settings.
Cost savings exceeding expectations
Provider Network Solutions has provided independent validation of the platform’s commercial efficacy, with CEO Dr Jose Pelayo confirming results surpass initial projections.
Dr Jose Pelayo, CEO of Provider Network Solutions
“We view a savings rate of 3%–5% of the US$35 per member per month duplicate imaging costs as material savings, and we are currently exceeding all our expectations.”
Dr Pelayo noted that based on outcomes PNS is experiencing, the 3DICOM platform is positioned to attract broader interest from additional U.S. healthcare plans. PNS has stated its belief in the “future financial and commercial scaleability” of the platform.
The 3-5% savings target against a US$35 per member per month duplicate imaging cost baseline provides a measurable benchmark for platform performance. Dr Pelayo’s confirmation that PNS is “currently exceeding all our expectations” offers third-party validation beyond company claims.
Renewal and expansion discussions underway
Following the initial term of the Binding Enterprise Agreement, Singular Health and Provider Network Solutions have commenced discussions regarding potential expansion and renewal of licensing arrangements.
Chong emphasised the platform is demonstrating “tangible cost savings and workflow efficiencies in a real-world healthcare environment” as deployment progresses.
Current commercial progress indicators include:
- US$500,000 payment received
- 500 additional licences deployed
- Increasing utilisation in clinical workflows
- Meaningful cost savings through reduction of duplicate imaging
- Renewal and expansion discussions commenced
The progression from initial contract to renewal discussions suggests potential for recurring revenue and expanded deal scope, providing near-term visibility on commercial trajectory.
Platform positioning for broader U.S. market
Dr Pelayo stated that outcomes from PNS usage position 3DICOM to “attract broader interest from more U.S. healthcare plans” as results are utilised. PNS expressed its belief in the “financial and commercial scaleability” of the platform based on observed performance.
The PNS relationship functions as a proof-of-concept for the broader U.S. managed care market. Success within PNS’s 4.2 million member network creates a reference case for approaching other healthcare organisations, particularly those seeking to reduce duplicate imaging costs whilst improving provider interoperability.
Key deal metrics at a glance
| Metric | Detail |
|---|---|
| Payment received | US$500,000 |
| Licences deployed | 500 additional 3DICOM MD licences |
| PNS covered lives | 4.2 million |
| Next steps | Renewal and expansion discussions commenced |
The next major ASX story will hit our subscribers first
What comes next for Singular Health
Near-term catalysts centre on renewal discussions with Provider Network Solutions, which have commenced following completion of the initial contractual term. Potential exists for expanded licensing arrangements based on platform performance to date.
The opportunity for additional U.S. healthcare plan customers builds on outcomes PNS is experiencing, as Dr Pelayo indicated the platform is positioned to attract broader market interest. The company’s forward commercial trajectory depends on converting initial deployment success into expanded arrangements, both with PNS and potential new healthcare organisation customers.
Investors now have a defined upcoming catalyst to monitor through the renewal and expansion discussions, which will indicate whether initial commercial traction translates into sustained revenue growth.
Want the Next Healthcare Breakthrough in Your Inbox?
Join 20,000+ investors getting FREE breaking ASX healthcare news delivered within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to receive real-time alerts the moment market-moving announcements break across ASX healthcare and tech sectors.